Synergy Pharmaceuticals, Inc.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Synergy Pharmaceuticals, Inc. had no revenue when it filed its newest notice of a funding round (Jun 2011).
SEC Form D (revenue range) · Jun 2011
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jun 2011
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Synergy Pharmaceuticals, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Bernard K Denoyer | Executive officer | Jun 2011 |
| Gary S Jacob | Executive officer | Jun 2011 |
| Kunwar M Shailubhai | Executive officer | Jun 2011 |
| Bernard K. Denoyer | Executive officer | Nov 2009 |
| Gary S. Jacob | Executive officer | Nov 2009 |
| Kunwar M. Shailubhai | Executive officer | Nov 2009 |
| Bernard Denoyer | Executive officer | Jul 2009 |
| Kunwar Shailubhai | Executive officer | Jul 2009 |
| Alan H Joslyn | Director | Jun 2011 |
| Chris H McGuigan | Director | Jun 2011 |
| Gabriel M Cerrone | Director | Jun 2011 |
| Gary S Jacob | Director | Jun 2011 |
| John M Brancaccio | Director | Jun 2011 |
| Melvin K Spigelman | Director | Jun 2011 |
| Thomas H Adams | Director | Jun 2011 |
| Gabriele M. Cerrone | Director | Nov 2009 |
| Gary S. Jacob | Director | Nov 2009 |
| John K. Brancaccio | Director | Nov 2009 |
| Melvin K. Spigelman | Director | Nov 2009 |
| Thomas H. Adams | Director | Nov 2009 |
| John Brancaccio | Director | Jul 2009 |